Regeneron Completes Purchase of Sanofi's Stake in Libtayo® …
https://investor.regeneron.com/news-releases/news-release-details/regeneron-completes-purchase-sanofis-stake-libtayor-cemiplimab
WebTARRYTOWN, N.Y., July 1, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has completed the acquisition of Sanofi's stake in Libtayo ® (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in …
DA: 84 PA: 8 MOZ Rank: 1